Fortis Healthcare Ltd
NSE: FORTIS · Hospital · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹561 cr vs borrowings ₹2,873 cr (FY26): borrowings are higher by ₹2,312 cr.
- Operating profit covered interest 5.2x in the last 12 months.
- No promoter shares are pledged.
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 5% of net profit in the last 12 months.
- Dividend paid in 3 of the last 5 financial years.
- Price ₹734.70 on 2026-10-26: -33.5% from the 52-week high, +1.9% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,988 | 1,928 | 2,007 | 2,167 | 2,331 | 2,265 | 2,365 | 2,545 |
| EBITDA | 375 | 399 | 382 | 503 | 580 | 460 | 520 | 547 |
| OPM % | 18.9% | 20.7% | 19.0% | 23.2% | 24.9% | 20.3% | 22.0% | 21.5% |
| Other income | 13 | 21 | 20 | 15 | 23 | 8 | 4 | 14 |
| Net profit | 176 | 248 | 184 | 260 | 322 | 194 | 266 | 266 |
| EPS (₹) | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 |
| Revenue YoY | +17.3% | +17.5% | +17.8% | +17.5% | ||||
| Profit YoY | +83.1% | -21.9% | +44.6% | +2.3% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 | 9,506 |
| EBITDA | 1,384 | 1,175 | 1,284 | 1,499 | 2,063 | 2,106 |
| Net profit | 555 | 589 | 599 | 774 | 1,042 | 1,048 |
| EPS (₹) | 7.35 | 7.80 | 7.93 | 10.26 | 13.80 | 13.88 |
| Revenue growth | +10.1% | +9.5% | +12.9% | +17.3% | +17.5% | |
| Profit growth | +6.1% | +1.7% | +29.3% | +34.6% | +20.7% | |
| Dividend / share (₹) | – | – | 1.00 | 1.00 | 1.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +13.2% | +17.8% | +17.5% |
| Net profit | +21.0% | – | +20.7% |
| EPS | +20.9% | – | – |
| Share price | – | +9.5% (2y) | -33.6% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 7,242 | 7,663 | 8,917 | 9,896 |
| Borrowings | – | 926 | 858 | 2,475 | 2,873 |
| Cash & equivalents | – | 363 | 598 | 508 | 561 |
| Total assets | – | 12,434 | 13,289 | 13,692 | 15,966 |
| Fixed assets | – | 4,850 | 5,268 | 5,848 | 5,348 |
| Capital work in progress | – | 228 | 540 | 404 | 432 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 582 | 628 | 784 | 1,044 |
| Inventory | – | 123 | 107 | 115 | 135 |
| Payables | – | 714 | 728 | 808 | 943 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 865 | 822 | 1,100 | 1,424 | 1,602 |
| Cash from investing | -514 | -374 | -886 | -779 | -1,538 |
| Cash from financing | -517 | -471 | -86 | -714 | 164 |
| Capex | 215 | 447 | 942 | 847 | 946 |
| Free cash flow | 650 | 375 | 158 | 577 | 656 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 8.1% | 7.8% | 8.7% | 10.5% |
| ROCE % | – | 11.3% | 11.5% | 10.4% | 13.0% |
| Debtor days | – | 34 | 33 | 37 | 42 |
| Inventory days | – | 31 | 24 | 23 | 24 |
| Payable days | – | 179 | 164 | 161 | 165 |
| Cash conversion cycle (days) | – | -114 | -107 | -101 | -99 |
| Working capital days | – | 30 | -52 | 26 | -12 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 31.17% |
| FIIs | 23.19% |
| DIIs | 34.46% |
| of which Mutual funds | 26.94% |
| of which Insurance | 5.18% |
| Government | 0.00% |
| Public (non-institutions) | 11.18% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| Promoter group | % |
|---|---|
| Northern TK Venture PTE. Ltd. | 31.17% |
| Public holders above 1% | % |
|---|---|
| Kotak Mahindra Trustee Co Ltd A/C Kotak Nifty Midc | 5.93% |
| HDFC Large and MID CAP Fund | 5.62% |
| Rekha Jhunjhunwala | 4.02% |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual F | 2.97% |
| Nippon Life India Trustee Ltd-a/c Nippon India ARB | 2.87% |
| SBI Life Insurance Co. Ltd | 1.80% |
| DSP Arbitrage Fund | 1.63% |
| Amansa Holdings Private Limited | 1.56% |
| SBI Midcap Fund | 1.42% |
| Axis Bank Limited | 1.19% |
| HDFC Life Insurance Company Limited | 1.18% |
| Edelweiss Nifty Largemidcap250 Plus 8-13 YR G-sec | 1.14% |
| Aditya Birla SUN Life Mutual Fund - Aditya Birla S | 1.14% |
| Axis MAX Life Insurance Limited A/C - Ulif00125/06 | 1.09% |
| Jupiter India Fund | 1.03% |
2,17,704 shareholders. Pledged: 0.00% of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| RAINBOW | ₹11,802 cr | 41.3x | 7.2x | 18.3% | 27.4% | 31.5% | +13.2% | 0.26% |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Healthcare | ₹7,773 cr | 83.6% | ₹1,394 cr | 17.9% |
| Diagnostics | ₹1,527 cr | 16.4% | ₹242 cr | 15.8% |
| Inter Segment | ₹0 cr | – | ₹0 cr | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-24 | Dividend | Dividend - Re 1 Per Share |
| 2025-07-25 | Dividend | Dividend - Re 1 Per Share |
| 2024-07-24 | Dividend | Dividend - Re 1 Per Share |
| 2023-07-20 | Dividend | Dividend - Re 1 Per Share |
| 2016-09-16 | Other | Annual General Meeting |
| 2015-09-14 | Other | Annual General Meeting |
| 2014-09-18 | Other | Annual General Meeting |
| 2013-09-19 | Other | Annual General Meeting |
| 2012-09-21 | Other | Annual General Meeting |
| 2011-09-12 | Other | Annual General Meeting |
| 2010-09-13 | Other | Annual General Meeting |
| 2009-09-22 | Other | Annual General Meeting |
| 2009-08-18 | Other | Rhts Eq 2:5 & 2 Wrnt:2 Eq |
| 2008-09-10 | Other | Annual General Meeting |
| 2007-09-19 | Other | Agm |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Hospital and Medical Care: Hospital activities
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | FORTIS |
| BSE code | 532843 |
| ISIN | INE061F01013 |
| Face value | ₹10.0 |
| Incorporated | 1996-02-28 |
| Website | www.fortishealthcare.com |
| Plants (India / abroad) | 0 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.